Blog

/Blog

FDA Approves First Drug for Treatment of Parkinson’s Dyskinesia

The US Food and Drug Administration (FDA) has approved amantadine extended-release capsules (Gocovri, Adamas Pharmaceuticals Inc) for treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications, the [...]

August 31st, 2017|News|

FDA Approves First Drug for cGVHD After Stem Cell Transplant

In a first, the US Food and Drug Administration (FDA) has approved a drug for use in  patients who develop the life-threatening condition of chronic graft-vs-host disease (cGVHD) after having undergone a hematopoietic stem cell [...]

August 30th, 2017|News|

Artificial Sweeteners Linked to Higher BMI, Cardiometabolic Risk

A new meta-analysis and systematic review finds mixed evidence to support use of artificial sweeteners for weight loss and suggests routine consumption may be associated with long-term weight gain and an increased risk of cardiometabolic [...]

August 29th, 2017|News|

FDA Approves Deflazocort (Emflaza®) To Treat Duchenne Muscular Dystrophy (DMD)

On February 9th, 2017 the U.S. Food and Drug Administration (FDA) approved Emflaza® (deflazacort) tablets and oral suspension to treat patients age 5 years and older with Duchenne muscular dystrophy (DMD), a rare genetic disorder [...]

February 15th, 2017|Blog, News, Pharmacy|

Mounting Problem of Opioid Diversion: Major Emerging Problem for Health Systems in US

The fight against the diversion of opioids and other controlled substances is heating up in the nation’s health systems, according to experts at a packed session at the 2016 annual meeting of the American Society [...]

January 17th, 2017|Blog, Pharmacy|

Pioglitazone Helps Prevent Secondary Stroke In Patients With Insulin Resistance

Data from a new systematic review and meta-analysis provides evidence the pioglitazone can help prevent secondary stroke in people with abnormal glucose metabolism. Pioglitazone reduced major vascular events after ischemic stroke in a recent randomized [...]

January 17th, 2017|Blog, News|